OTOMAX OINTMENT

Country: অস্ট্রেলিয়া

ভাষা: ইংরেজি

সূত্র: APVMA (Australian Pesticides and Veterinary Medicines Authority)

সক্রিয় উপাদান:

GENTAMICIN SULFATE; CLOTRIMAZOLE; BETAMETHASONE VALERATE

থেকে পাওয়া:

INTERVET AUSTRALIA PTY LIMITED

INN (International Name):

gentamicin(2640IU/mL)+betamethasone as valerate(0.88mg/mL) + others

ফার্মাসিউটিকাল ফর্ম:

TOPICAL CREAM, OINTMENT, PASTE, GEL, LOTION

রচনা:

GENTAMICIN SULFATE ANTIBIOTIC Active 2640.0 IU/ml; CLOTRIMAZOLE IMIDAZOLE Active 8.8 mg/ml; BETAMETHASONE VALERATE STEROID-GLUCOCORTICOID Active 1.07 mg/ml

প্যাকেজ ইউনিট:

!12x7.5g; !tubes; *12x15g; *tubes; 12x14mLbot; 12x17mL; 14mL bot; 15g tube; 17mL; 240mL bot; 34mL bot; 6x34mL bot; 7.5g tubes

শ্রেণী:

VM - Veterinary Medicine

Manufactured by:

INTERVET AUSTRALIA

Therapeutic group:

DOG | BITCH | CASTRATE | PUPPY

Therapeutic area:

EAR,NOSE,THROAT + DERMAL

থেরাপিউটিক ইঙ্গিত:

OTITIS EXTERNA | ACUTE CANINE OTITIS | ASSOCIATED WITH YEAST &/OR BAC | CHRONIC CANINE OTITIS | MALASSEZIA PACHYDERMATIS | OTITIS (CANINE)

পণ্য সারাংশ:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [OTITIS EXTERNA]; For the treatment of canine acute and chronic otitis externa associated with yeast (Malassezia pachydermatis) and/or bacteria susceptible to gentamicin.DO NOT use in animals with known perforation of the eardrum (tympanic membrane). DO NOT use in pregnant or lactating animals. DO NOT use concomitantly with drugs known to induce ototoxicity. NOT FOR USE in food producing animals.

অনুমোদন অবস্থা:

Registered

অনুমোদন তারিখ:

2023-07-01

তথ্য লিফলেট

Registered
Product
Name:
OTOMAX
Ointment
Page 1
of
6
Pack
Sizes:
7.5g [15g, 14 mL, 34 mL, 240 mL,
12
x 7.5g,
12
x
Date (Version Control):
26/09/2013
1
5g,
12
x 14mL, 6 x 34 mL]
Description:
Primary
Carton
APVMA: 51104/58945
Panel labels,
text
above the
header
and
below
the
footer
are
not
included
in
this label text.
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
READ SAFETY DIRECTIONS BEFORE OPENING
OR
USING
FOR ANIMAL TREATMENT ONLY
OTOMAX®
OINTMENT
RLP
Approved
ACTIVE INGREDIENTS:
GENTAMICIN SULFATE equivalent to 2640
IU
Gentamicin Base, 1.
07mg
BET
AM
ETHASONE VALERATE equivalent to 0.88
mg
Betamethasone and 8.80 mg
CLOTRIMAZOLE per
ml.
For the treatment of canine acute and chronic otitis externa associat
ed
with yeast
(Malassezia
pachydermatis)
and/or bacteria susceptible to gentamicin.
7.
5g
[1
5g,14 mL, 34 mL, 240 mL, 12 x 7.
5g
,
12
x 15g, 12 x 14mL, 6 x 34 mL]
MSD logo
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT
DIRECTIONS FOR USE:
Restraint
NOT FOR USE
in
food-producing
animals.
Contraindications
Contraindicated
for
use
in
animals
with
known
perforation
of
the
eardrum
(tympanic
membrane).
Contraindicated
for
use in
pregnant
or
lactating
animals.
Contraindicated
for
concomitant
use
with
drugs
known
to
induce
ototoxicity.
Precautions
If hyper-sensitivity to any component occurs, discontinue treatment
and institute appropriate therapy.
Avoid
co
ncomitant use of drugs known
to
induce ototoxicity.
Administration
of
recommended doses
beyond 7 days may result in delayed wound healing.
Prolo
ng
ed use or overdosage may produce
adverse immun
os
uppressive effect
s.
Antibiotic susceptibility of the pathogenic organism(s) should be
determined prior to use of this preparation.
Dosage and
Administration
SHAKE
WELL
BEFORE USE.
Th
oroughly clean and dry external ear.
Rem
ove foreign mater
ia
l, crusted and d
ri
ed
debris etc. with a
non-irritating
solution.
Cl
ip excessi
ve
hair from treatment area.
Examine ear
ca
nal
to
ensure
tympanic membrane
is
not ruptured.
Dogs less th
an
15kg: 4 dro
ps.
Dogs 1

পণ্য বৈশিষ্ট্য

PRODUCT NAME: OTOMAX OINTMENT
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: AUGUST, 2009
PAGE: 1 OF 5
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: [phone]
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
Suspension of ingredients in water.
TRADE NAME:
OTOMAX OINTMENT
RECOMMENDED USE:
For the treatment of canine acute and chronic otitis externa
associated with yeast and/or
bacteria susceptible to gentamicin.
APVMA NO:
51104
CREATION DATE:
August, 2009
THIS VERSION ISSUED:
August, 2009
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S24/25. Avoid contact with skin and eyes.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
A white to off white viscous suspension.
ODOUR:
no data.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product. This is
an antibiotic preparation.
Any person with a history of allergies to this class of substances
should avoid all contact with this product as it may cause
sensitisation. This is a physiologically active product and so contact
should be minimised, especially if the user is taking a
form of medication, as interactions can sometimes give unexpected and
undesired results.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. In addition
product is unlikely to
cause any discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. However product may be mildly irr